pharma · Multiple Myeloma · Renal Cell Cancer · CRVS
Corvus Pharmaceuticals
Corvus Pharmaceuticals trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Burlingame, USA
- Founded
- 2014
- Employees
- 48
- Programs
- 9
- Drugs
- 4
- Patents
- 14
Corvus Pharmaceuticals clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Corvus Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Corvus Pharmaceuticals trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Corvus Pharmaceuticals.
-
CPI-006 — Phase 1
Clinical update -
CPI-006 2 mg/kg + SOC — Phase 3
Clinical update -
Soquelitinib — Phase 3
Clinical update -
CPI-818 — Phase 1
Clinical update -
CPI-444 Capsules — Phase 1
Clinical update -
Soquelitinib — Phase 2
Clinical update -
CPI-006 — Phase 1
Clinical update -
Ciforadenant — Phase 1
Clinical update